Intra-Cellular Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Intra-Cellular Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Intra-Cellular Therapies (ITCI) Misses Q2 EPS by 5c

August 9, 2021 7:33 AM EDT

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q2 EPS of ($0.85), $0.05 worse than the analyst estimate of ($0.80). Revenue for the quarter came in at $20 million versus the consensus estimate of $19.44 million.

For earnings history and earnings-related data on Intra-Cellular Therapies (ITCI) click here.

... More